|
|
Lab Dept:
|
Serology
|
Test Name:
|
LYMPHOCYTIC CHORIOMENINGITIS VIRUS ANTIBODY
|
General Information
|
Lab Order Codes:
|
LCMV
|
Synonyms:
|
LCM Antibody
|
CPT Codes:
|
86272 x2 – Antibody, lymphocytic choriomeningitis
|
Test Includes:
|
IgG and IgM lymphocytic choriomenigitis antibodies reported as titers.
|
Logistics
|
Test Indications:
|
N/A
|
Lab Testing Sections:
|
Serology - Sendouts
|
Referred to:
|
Mayo Medical Laboratories forward to Focus Technologies, Inc. (MML Test# 90042) (Focus Test# 40625)
|
Phone Numbers:
Minneapolis:
Saint Paul:
|
|
612-813-6280
|
651-220-6550
|
Test Availability:
|
Daily, 24 hours
|
Turnaround Time:
|
1 – 4 days, test setup Monday - Friday
|
Special Instructions:
|
Mislabeled or unlabeled specimens
|
Specimen
|
Specimen Type:
|
Blood
|
Container:
|
Red top tube
|
Draw Volume:
|
3.0 mL blood
|
Processed Volume:
|
1.0 mL (Minimum: 0.25 mL) serum
|
Collection:
|
Routine venipuncture
|
Special Processing:
|
Lab Staff: Centrifuge specimen, remove serum aliquot into a screw-capped round bottom plastic vial. Store and ship at refrigerated temperatures. Forward promptly.
|
Patient Preparation:
|
None
|
Sample Rejection:
|
N/A
|
Interpretive
|
Reference Range:
|
IgG: <1:16
IgM:<1:20
Antibody to LCM is often detectable within a few days of clinical symptoms. An elevated IgM titer is indicative of recent or current infection. A four-fold rise in IgG titer between acute and convalescent specimens also indicates recent infection.
This assay was developed and its performance characteristics determined by Focus Technologies. It has not been cleared or approved by the US Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary.
|
Critical Values:
|
N/A
|
Limitations:
|
N/A
|
Methodology:
|
Indirect Fluorescent Antibody (IFA)
|
Contraindications:
|
N/A
|
References:
|
Mayo Medical Laboratories Web Page April 2007
|
Focus Technologies, Inc. Web Page April 2007
|
